Read more about the article Rejuvenate Bio Started With Treating Dogs: Why That’s a Win 
Scientist working with microscope in laboratory. Medical research

Rejuvenate Bio Started With Treating Dogs: Why That’s a Win 

An investment perspective by Doug Sylvester, General Partner, Xcellerant Ventures, and Fund Manager, Jetstream Venture Fund  Jetstream recently invested in Rejuvenate Bio, a San Diego gene therapy company focused on…

Continue ReadingRejuvenate Bio Started With Treating Dogs: Why That’s a Win 
Read more about the article SpaceX Advances Toward Potential IPO: Recent Market Developments
An artist's depiction of the SpaceX Crew Dragon on Mars. (Image credit: SpaceX)

SpaceX Advances Toward Potential IPO: Recent Market Developments

In early April 2026, multiple media outlets reported that SpaceX submitted draft registration documents to the U.S. Securities and Exchange Commission as it prepares for a potential initial public offering…

Continue ReadingSpaceX Advances Toward Potential IPO: Recent Market Developments